Ceramide in the antiapoptotic effect of ischemic preconditioning

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 286, Issue 1 55-1, 2004, Pages

  Argaud, Laurent ^a   Prigent, Annie France ^b   Chalabreysse, Lara ^a   Loufouat, Joseph ^a   Lagarde, Michel ^b   Ovize, Michel ^a,c  

^a UNIVERSITÉ LYON 1   (France)

^b UNIVERSITÉ DE LYON   (France)

^c INSERM   (France)

Author keywords

Apoptosis; Ischemia; Necrosis; Reperfusion

Indexed keywords

CERAMIDE; DIACYLGLYCEROL; DIACYLGLYCEROL KINASE; DYE; SPHINGOMYELIN PHOSPHODIESTERASE INHIBITOR; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE; TRIPHENYLTETRAZOLIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART MUSCLE CELL; HEART MUSCLE REPERFUSION; IN VIVO STUDY; ISCHEMIA; MALE; NECROSIS; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0347628961     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00638.2003     Document Type: Article

References (35)

1. Beresewicz A, Dobrzyn A, and Gorski J. Accumulation of specific ceramides in ischemic/reperfused rat heart; effect of ischemic preconditioning. J Physiol Pharmacol 53: 371-382, 2002.
2. Bielawska AE, Shapiro JP, Jiang L, Melkonyan HS, Piot C, Wolfe CL, Tomel LD, Hannun YA, and Umansky SR. Ceramide is involved in triggering of cardiomyocyte apoptosis induced by ischemia and reperfusion. Am J Pathol 151: 1257-1263, 1997.
3. Bose R, Verheij M, Haimovitz-Friedman A, Scotto K, Fuks Z, and Kolesnick R. Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell 82: 405-414, 1995.
4. Cifone MG, De Maria R, Roncaioli P, Rippo MR, Azuma M, Lanier LL, Santoni A, and Testi R. Apoptotic signaling through CD95 (Fas/ Apo-1) activates an acidic sphingomyelinase. J Exp Med 177: 1547-1552, 1993.
5. Folch J, Lees M, and Sloane Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226: 497-509, 1957.
6. Goldberg M, Zhang HL, and Steinberg SF. Hypoxia alters the subcellular distribution of protein kinase C isoforms in neonatal rat ventricular myocytes. J Clin Invest 99: 55-61, 1997.
7. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, and Engler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94: 1621-1628, 1994.
8. Gottlieb RA, Gruol DL, Zhu JY, and Engler RL. Preconditioning in rabbit cardiomyocytes: role of pH, vacuolar proton ATPase, and apoptosis. J Clin Invest 97: 2391-2398, 1996.
9. Gysemberg A, Margonari H, Loufoua J, Ovize A, André-Fouet X, Minaire Y, and Ovize M. Stretch-induced protection shares a common mechanism with ischemic preconditioning in the rabbit heart. Am J Physiol Heart Circ Physiol 274: H955-H964, 1998.
10. Gysemberg A, Zakaroff-Girard A, Loufoua J, Meunier L, André-Fouet X, Lagarde M, Prigent AF, and Ovize M. Brief preconditioning ischemia alters diacylglycerol content and composition in rabbit heart. Basic Res Cardiol 95: 457-465, 2000.
11. Hannun YA. Functions of ceramide in coordinating cellular response to stress. Science 274: 1855-1859, 1996.
12. Hausenloy DJ, Maddock HL, Baxter GF, and Yellon DM. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc Res 55: 534-543, 2002.
13. Jarvis WDJ, Fornari FA, Browning JL, Gerwirtz DA, Kolesnick RN, and Grant SG. Attenuation of ceramide-induced apoptosis by diglyceride in human myeloid leukemia cells. J Biol Chem 269: 31685-31692, 1994.
14. Javadov SA, Clarke S, Das M, Griffiths EJ, Lim KH, and Halestrap AP. Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart. J Physiol 549: 513-524, 2003.
15. Kolesnick R and Golde DW. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77: 325-328, 1994.
16. Lecour S, Smith RM, Woodward B, Opie LH, Rochette L, and Sack MN. Identification of a novel role for sphingolipid signaling in TNFα and ischemic preconditioning mediated cardioprotection. J Mol Cell Cardiol 34: 509-518, 2002.
17. Leist M, Gantner F, Bohlinger I, German PG, Tiegs G, and Wendel A. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF requires transcriptional arrest. J Immunol 153: 1778-1787, 1994.
18. Lin KM, Lin B, Lian IY, Mestril R, Scheffier IE, and Dillmann WH. Combined and individual mitochondrial HSP60 and HSP10 expression in cardiac myocytes protects mitochondrial function and prevents apoptotic cell death induced by simulated ischemia-reoxygenation. Circulation 103: 1787-1792, 2001.
19. Mathias S, Pena LA, and Kolesnick RN. Signal transduction of stress by ceramide. Biochem J 335: 465-480, 1998.
20. Maulik N, Engleman RM, Rousou JA, Flack JE, Deaton D, and Das DK. Ischemic preconditioning reduces apoptosis by upregulating anti-death gene Bcl-2. Circulation 100: II369-II375, 1999.
21. Murase K, Okumura K, Hayashi K, Matsui H, Toki Y, Ito T, and Hayakawa T. Measurement of 1,2-diacylglycerol and ceramide in hearts subjected to ischemic preconditioning. Life Sci 66: 1491-1500, 2000.
22. Nakamura M, Wang NP, Zhao ZQ, Wilcox JN, Thourani V, Guyton RA, and Vinten-Johansen J. Preconditioning decreases Bax expression, PMN accumulation and apoptosis in reperfused rat heart. Cardiovasc Res 45: 661-670, 2000.
23. Nishizuka Y. Intracellular signalling by hydrolysis of phospholipids and activation of protein kinase C. Science 258: 607-614, 1992.
24. Obeid LM, Linardic CM, Karolak LA, and Hannun YA. Programmed cell death induced by ceramide. Science 259: 1769-1771, 1993.
25. Okamura T, Miura T, Iwamoto H, Shirakawa K, Kawamua S, Ikeda Y, Iwatate M, and Matsuzaki M. Ischemic preconditioning attenuates apoptosis through protein kinase C in rat hearts. Am J Physiol Heart Circ Physiol 277: H1997-H2001, 1999.
26. Ovize M, Przyklenk K, and Kloner RA. Stretch preconditions the canine myocardium. Am J Physiol Heart Circ Physiol 266: H137-H146, 1994.
27. Pastorino JG, Simbula G, Yamamoto K, Glascott PA, Rothman RJ, and Farber JL. The cytotoxicity of tumor necrosis factor depends on induction of the mitochondrial permeability transition. J Biol Chem 271: 29792-29798, 1996.
28. Piot CA, Martini JF, Bui SK, and Wolfe CL. Ischemic preconditioning attenuates ischemia/reperfusion-induced activation of caspases and subsequent cleavage of poly(ADP-ribose) polymerase in rat hearts in vivo. Cardiovasc Res 44: 536-542, 1999.
29. Piot CA, Padmanaban DD, Ursell PC, Sievers RE, and Wolfe CL. Ischemic preconditioning decreases apoptosis in rat heart in vivo. Circulation 96: 1598-1604, 1997.
30. Preiss J, Loomis CR, Bishop WR, Stein R, Niedel JE, and Bell RM. Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes and ras- and sis-transformed normal rat kidney cells. J Biol Chem 261: 8597-8600, 1986.
31. Takeishi Y, Jalili T, Ball NA, and Walsh RA. Response of cardiac protein kinase C isoforms to distinct pathological stimuli are differentially regulated. Circ Res 85: 264-271, 1999.
32. Vivaldi MT, Kloner RA, and Schoen FJ. Triphenyltetrazolium staining of irreversible ischemic injury following coronary artery occlusion in rats. Am J Pathol 121: 522-530, 1985.
33. Yadav SS, Sindram D, Perry DK, and Clavien PA. Ischemic preconditioing protects the mouse liver by inhibition of apoptosis through a caspase-dependent pathway. Hepathology 30: 1223-1231, 1999.
34. Ytrehus K, Liu Y, and Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol Heart Circ Physiol 266: H1145-H1152, 1994.
35. Zhang DX, Fryer RM, Hsu AK, Zou AP, Gross GJ, Campbell WB, and Li PL. Production and metabolism of ceramide in normal and ischemic-reperfused myocardium of rats. Basic Res Cardiol 96: 267-274, 2001.